UBS Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-82,016
Closed -$3.15M 8980
2023
Q2
$3.15M Buy
82,016
+5,028
+7% +$193K ﹤0.01% 2291
2023
Q1
$1.78M Buy
76,988
+8,224
+12% +$190K ﹤0.01% 2698
2022
Q4
$1.8M Buy
68,764
+45,316
+193% +$1.19M ﹤0.01% 2642
2022
Q3
$461K Buy
23,448
+9,322
+66% +$183K ﹤0.01% 3436
2022
Q2
$248K Sell
14,126
-60,288
-81% -$1.06M ﹤0.01% 3793
2022
Q1
$1.22M Buy
74,414
+29,388
+65% +$481K ﹤0.01% 3060
2021
Q4
$735K Buy
45,026
+19,944
+80% +$326K ﹤0.01% 3684
2021
Q3
$320K Buy
25,082
+23,958
+2,131% +$306K ﹤0.01% 3979
2021
Q2
$16K Buy
+1,124
New +$16K ﹤0.01% 6502
2021
Q1
Sell
-380
Closed -$6K 8378
2020
Q4
$6K Hold
380
﹤0.01% 6764
2020
Q3
$5K Sell
380
-3,453
-90% -$45.4K ﹤0.01% 6472
2020
Q2
$44K Sell
3,833
-4,798
-56% -$55.1K ﹤0.01% 5131
2020
Q1
$118K Sell
8,631
-8,596
-50% -$118K ﹤0.01% 4295
2019
Q4
$102K Buy
17,227
+9,229
+115% +$54.6K ﹤0.01% 4969
2019
Q3
$42K Buy
7,998
+4,685
+141% +$24.6K ﹤0.01% 5346
2019
Q2
$26K Buy
3,313
+414
+14% +$3.25K ﹤0.01% 5576
2019
Q1
$58K Buy
2,899
+1,871
+182% +$37.4K ﹤0.01% 4639
2018
Q4
$14K Sell
1,028
-27
-3% -$368 ﹤0.01% 6134
2018
Q3
$39K Buy
1,055
+807
+325% +$29.8K ﹤0.01% 5456
2018
Q2
$9K Sell
248
-307
-55% -$11.1K ﹤0.01% 6290
2018
Q1
$25K Sell
555
-2,403
-81% -$108K ﹤0.01% 5396
2017
Q4
$111K Sell
2,958
-3,483
-54% -$131K ﹤0.01% 4352
2017
Q3
$343K Buy
6,441
+6,177
+2,340% +$329K ﹤0.01% 3694
2017
Q2
$15K Hold
264
﹤0.01% 5560
2017
Q1
$14K Sell
264
-1,635
-86% -$86.7K ﹤0.01% 5496
2016
Q4
$108K Buy
1,899
+1,608
+553% +$91.5K ﹤0.01% 4355
2016
Q3
$18K Sell
291
-205
-41% -$12.7K ﹤0.01% 5496
2016
Q2
$29K Sell
496
-1,560
-76% -$91.2K ﹤0.01% 5100
2016
Q1
$131K Buy
2,056
+1,582
+334% +$101K ﹤0.01% 4056
2015
Q4
$67K Buy
474
+326
+220% +$46.1K ﹤0.01% 4526
2015
Q3
$14K Buy
148
+97
+190% +$9.18K ﹤0.01% 5726
2015
Q2
$8K Buy
+51
New +$8K ﹤0.01% 6099